Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,598.60INR
1:31am EDT
Change (% chg)

Rs-146.40 (-5.33%)
Prev Close
Rs2,745.00
Open
Rs2,778.00
Day's High
Rs2,779.00
Day's Low
Rs2,590.00
Volume
934,925
Avg. Vol
867,279
52-wk High
Rs2,964.00
52-wk Low
Rs1,872.95

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.25
Market Cap(Mil.): Rs455,252.69
Shares Outstanding(Mil.): 165.85
Dividend: 20.00
Yield (%): 0.73

Financials

  REDY.NS Industry Sector
P/E (TTM): 23.38 54.03 55.51
EPS (TTM): 117.41 -- --
ROI: 11.83 11.89 11.59
ROE: 14.67 13.19 16.33

UPDATE 1-Indian drugmaker Dr. Reddy's Q3 profit surges on strong growth in emerging markets

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, handily beating market expectations, helped by strong growth in emerging markets.

Feb 01 2019

Indian drugmaker Dr. Reddy's Q3 profit rises 65.3 pct, beats estimates

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, driven by strong growth in emerging markets.

Feb 01 2019

Indivior plans cheaper opioid addiction drug if rivals launch copycats

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.

Dec 18 2018

Earnings vs. Estimates